From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
Webinar
Full-line pharmaceutical wholesale businesses are undergoing significant change. Confronted by fewer primary care brands going generic and cost pressure, wholesalers can no longer offer large manufacturers the same loss-leading distribution fees terms or service levels. On the other hand, some manufacturers cannot sustain increasing distribution costs due to gross to net pressure, and are moving towards new distribution models and providers. In summary, the numbers and complexity of managing distribution agreements are growing.
Against this backdrop, channel and market access leaders are struggling with holding their trading partners accountable to contractual commitments for data, inventory and service levels. Simultaneously, Trade Operations and Finance teams are often overwhelmed with the increased volume of contracts, payments and audit inquiries.
For more information on these trends, please contact ic@integrichain.com or reach out to David Weiss and Aaron Light.
David WeissVP, Industry Solutions
Aaron LightSolutions Manager
